References
Behçet H: Über rezidivierende aphthosc, durch ein Virus verusachte GeschwÜre am Mund, am Auge und an den Genitalien. Derm Wochenschr 1937:36:1152–1157.
Chajek-Shaul T, Pisanty S, Knobler H, et al: HIa-B51 may serve an immunogenetic marker for a subgroup of patients with Behçet’s disease. Am J Med 1987:83:666–672.
Cooper C, Pippard EC, Sharp H, et al: Is Behçet’s disease triggered by childhood infection? Ann Rheum Dis 1989;48:421–423.
Young C, Lehner T, Barnes CG, et al: CD4 and CD8 cell response to herpes simplex virus in Behçet’s disease. Clin exp Immunol 1988:73:6–10.
Davies UM, Palmer RG, et al: Treatment with a acyclovir does not affect orogenital ulcers in Behçet’s syndrome: A randomized double blind trial. Br J Rheumatol 1988:27:300–302.
Mizushima Y, Matsuda T, Hoshi K, et al: Induction of Behçet’s disease symptoms after dental treatment and streptococcal antigen skin test. J Rheumatol 1988:15:1029–1030.
Niwa Y, Mizushima Y: Neutrophil-potentiating factors released from stimuIated lymphocytes: Special reference to the increase in neutrophil-potentiating factors from streptococcus-stimulated lymphocytes of patients with Behçet’s disease. Clin exp Immunol 1990;79;353–360.
Efthimiou J, Addison IE, Johnson BV, et al: In vivo leucocyte mygration in Behçet’s syndrome. Ann Rheum Dis 1989;48:206–210.
Suzuki N, Sakane T: Abnormal B cell function in patients with Behçet’s disease. Arthritis Rheum 1986:29:212–219.
Hamzaoui K, Ayed Kh, Hamaza M, et al: Natural killer cells in Behçet’s disease. Clin exp Immunol 1988:71:126–131.
Sakane T, Suzuki N, Ueda Y, et al: Analysis of interleukin-2 activity in patients with Behçet’s disease: Ability of T cells to produce and respond to interleukin-2. Arthritis Rheum 1986;29: 371–378.
Golstein SJ, Mackenzie-Crooks DJ: Colitis in Behçet’s disease: Two new cases. Radiology 1978:128:321–323.
Mizushima Y, Inaba G, Miura Y, et al: Diagnostic criteria for Behçet’s disease in 1987, and guidlines for treating Behçet’s disease. Saishin-Igaku 1988:43:382–391. (In Japanese)
International Study Group for Behçet’s Disease: Criteria for diagnosis of Behçet’s disease. Iancet 1990;335:1078–1080.
Honma T, Bang T, Saito T, et al: Ultrastructure of lymphocytemediated fat-cell lysis in erythema nodosum-like lesions of Behçet’s disease. Arch Dermatol 1987;123:650–654.
Barbas CSV, deCalvalho CRR, Delmonte VC, et al: Behçet’s disease: A rare case of simultaneous pulmonary and cerebral involvement. Am J Med 1988:85:576–578.
Raz I, Okon E, Chajek-Shaul T: Pulmonary manifestations in Behçet’s syndrome. Chest 1989:95:585–589.
Efthimiou J, Johatons C, Spiro SG, et al: Pulmonary disease in Behçet’s syndrome. Q J Med 1986:227:259–280.
Malik GH, Sirwae IA, Pandit KA: Behçet’s syndrome associated with minimal change glomerulonephritis and renal vein thrombosis. Ncphron 1989:52:87–89.
Donnelly S, Jothy S, Barre P: Crescentic glomerulonephritis in Behçet’s syndrome-Results of therapy and review of the literature. Clin Nephrol 1989:31:213–218.
Delsen N, Konice M, Aral O, et al: Behçet’s disease associated with amyloidosis in Turkey and in the world. Ann Rheum Dis 1988:47:157–163.
Bemelman FJ, Krediet RT, Scipper MEI, et al: Renal involvement in Behçet’s syndrome: Report of a case and a review of the literature. Neth J Med 1989;34:148–153.
Bletry O, Mohattane S, Welcher B, et al: Cardiac manifestation of Behçet’s disease: Twelve cases. Presse Med 1988:17:2388–2391.
Wilson AP, Efthimiou J, Betterridge DJ, et al: Decreased prostacyclin sensitivity of pIatelets in patients with Behçet’s syndrome. Eur J Clin Invest 1988:18:410–414.
Aitchison R, Chu P, Carter DR, et al. Defective fibrinolysis in Behçet’s syndrome: Significance and possible mechanisms. Ann Rheum Dis 1989:48:590–593.
Serdaroglu P, Yazici H, Ozdermir C, et al: Neurologic involvement in Behçet’s syndrome. Arch Neurol 1989:46:265–269.
Herskovitz S, Lipton RB, Iantos G: Neuro-Behçet’s disease: CT and clinical correIates. Neurology 1988:38:1714–1720.
Shimizu T, Ehrlich GE, Inaba G, et al: Behçet disease (Behçet syndrome). Seminars Arthritis Rheum 1979:8:223–260.
Yim CW, White RH: Behçet’s syndrome in a family with infIammatory bowel disease. Arch Intern Med 1985:146:1047–1050.
Yashiro K, Nagasako K, Hasegawa K, et al: Esophageal lesions in intestinal Behçet’s disease. Endoscopy 1986:18:57–60.
Anti M, Marra G, Rapaccini GL, et al: Esophageal involvement in Behçet’s syndrome. J Clin Gastroenterol 1986:8:514–519.
Satake K, Yada K, Ikehara T, et al: Pyrolic stenosis: Unusual complication of Behçet’s disease. Am J Gastroenterol 1986;81: 816–818.
Ozenç A, Bayraktar Y, Baykal A: Pyrolic stenosis with esophageal involvement in Behçet’s syndrome. Am J Gastroenterol 1990:85:717–718.
Lee RG: The Colitis in Behçet’s syndrome. Am J Surg Pathol 1986:10:888–893.
Smith GE, Kime LR, Pitcher JL: The Colitis of Behçet’s disease: A separate entity?: Colosopic findings and literature review. Digestive Dis 1973:18:987–1000.
Suematsu M, Suzuki M, Kitahora T, et al: Increased respiratory burst of leukocytes in infIammatory bowel disease: The analysis of free radical generation by using chemiluminescence probe. J Clin Iab Immunol 1987;24:125–128.
Niwa Y, Soniya K, Michelson AM, et al: Effect of liposomal encapsuIated Superoxide dismutase on active oxygen-reIated human disorders. Free Radic Res Commun 1985;1:137–153.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Inoue, T., Satake, K. Behçet’s disease. Gastroenterol Jpn 26, 685–690 (1991). https://doi.org/10.1007/BF02781691
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF02781691